Lutein Supplementation May Improve Outcomes in Early AMD - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease

  • By

  • Andrea Surnit

  • May 5, 2026

  • 3 min

Share

  • 1

    Lutein supplementation improves macular pigment optical density and best-corrected visual acuity in early-stage age-related macular degeneration.

  • 2

    The systematic review analyzed nine randomized trials involving 860 patients, showing significant benefits of lutein compared to placebo.

  • 3

    Improvements in visual outcomes were statistically significant for early-stage AMD but not for late-stage or mixed-stage populations.

  • 4

    Longer supplementation duration and higher cumulative lutein exposure correlated with greater changes in visual outcomes.

  • 5

    The study highlights the need for longer follow-up to assess lutein's effects on AMD progression and long-term vision outcomes.

Original Source(s)

Lutein Supplementation May Improve Outcomes in Early AMD

  • by Andrea Surnit

  • May 5, 2026

Related Content

Vascular Alterations in the Choroid of Eyes Affected by Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy: Fresh Perspectives

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration

Blindness Linked to Higher Loneliness Scores

Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.